AGA Medical Corporation, a Plymouth, Minnesota firm, has received the CE Mark of Approval from the European Union to market the company’s latest vascular plug, the AMPLATZER® Vascular Plug III, designed to embolize blood vessels in the peripheral vasculature.
The AVP III is a self-expanding nitinol mesh device and is designed to be introduced in a minimally invasive fashion through a catheter. The device comes pre-attached to a delivery cable by a small screw; the delivery cable enables the physician to precisely position the device in the targeted blood vessel. Once positioned, the cable is unscrewed and the device is released. The nitinol mesh retention discs ensure the secure positioning of the device even in high flow vessels.
Press release: AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER® Vascular Plug III …
Produce page: AGA Medical’s vascular plug page…